ASKG-315

N/A

Report date: 2023/12/08 10:50:03

Base Information

Drug NameASKG-315
Drug Alias NameASKG-315ASKG-215bASKG-215β
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein
Mechanisms of ActionInterleukin-15 receptor subunit alpha agonists
TargetsInterleukin-15 receptor subunit alpha
Therapy Area/IndicationsSolid tumoursNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesAskgene Pharma
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A